Actelion drug cuts brain lesions in MS patients

Links shared publicly online about this topic.

  • 102
    total visits

Actelion drug cuts brain lesions in MS patients

health.yahoo.net

Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.

View full resource at health.yahoo.net

Tags: Brain, Multiple Sclerosis, Multiple Sclerosis Medication, Drug

  • Share

Most Recently Shared on August 2, 2011 at 9:40 am By:

HealthSociety Healthy Society

Actelion drug cuts brain lesions in MS patients http://bit.ly/quxJeX

9 months ago...

Actelion drug cuts brain lesions in MS patients - Yahoo! News

news.yahoo.com — “Read 'Actelion drug cuts brain lesions in MS patients' on Yahoo! News. ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 2:15 pm By:

MS_Wisdom2 OrganizedWisdom MS OW Health

Actelion drug cuts brain lesions in MS patients: ZURICH (Reuters) - Actelion's experimental multiple sclerosis ... http://yhoo.it/nkwIIo

9 months ago...

Actelion drug cuts brain lesions in MS patients | Reuters

reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy rideView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 11:09 am By:

FierceBiotech FierceBiotech Health News

RT @MaureenFierce: Actelion's experimental multiple sclerosis drug ponesimod met main goal in Phase II trial. http://reut.rs/odFNOF

9 months ago...

Actelion drug cuts brain lesions in MS patients | Reuters

reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy rideView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 11:00 am By:

Reuters_Health Reuters Health Health News

Drug cuts brain lesions in MS patients: Actelion study http://reut.rs/qTZCcT

9 months ago...

Actelion drug cuts brain lesions in MS patients

health.yahoo.net — “Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 9:58 am By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

Actelion drug cuts brain lesions in MS patients: Actelion's experimental multiple sclerosis drug ponesimod met i... http://bit.ly/nTUdDA

9 months ago...

Actelion drug cuts brain lesions in MS patients

health.yahoo.net — “Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 9:42 am By:

Actelion drug cuts brain lesions in MS patients | Reuters

reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy rideView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 7:54 am By:

HealthNews2 Health News Health News

Drug cuts brain lesions in MS patients: Actelion study: ZURICH (Reuters) - Swiss biotech company A... http://bit.ly/nxrPjY #health #news

9 months ago...

Actelion drug cuts brain lesions in MS patients | Reuters

reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy rideView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 6:18 am By:

MedicalFeed MedicalFeed Health News Feed

Drug cuts brain lesions in MS patients: Actelion study: ZURICH (Reuters) - Swiss biotech… http://goo.gl/fb/nG3rE

9 months ago...

Actelion drug cuts brain lesions in MS patients | Reuters

reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy rideView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 5:53 am By:

kieran_breen Kieran Breen Research

RT @MedicalNews Drug cuts brain lesions in MS patients: Actelion study http://bit.ly/re6iDO

9 months ago...

Advertisement